Vioxx Litigation Attorneys

in Colorado and Nationwide

Vioxx (generic name: rofecoxib) is a is a Cox-2 inhibitor in the same drug class as Celebrex and Bextra. The FDA approved Vioxx in May 1999 following various trials and tests. Vioxx was marketed based upon the claim that it could provide the same effects of a non-steroidal anti-inflammatory drug NSAID) without causing the gastric problems that commonly came with traditional NSAIDs. Then, in September 2004, continued testing indicated that Vioxx reduced the risk of stomach problems in patients but significantly increased the risk of heart attacks and strokes. On September 30, 2004 Merck announced the worldwide withdrawal of Vioxx from the market. Contrary to earlier reports that increased heart risks appeared after more than 18 months' worth of use, the evidence now shows that heart risks could occur after as few as three months of Vioxx use.

Burg Simpson has significant experience with Vioxx cases. Michael S. Burg was appointed to the Vioxx MDL State Liaison Committee, which coordinates state and federal Vioxx litigation.

To date, a number of Vioxx cases have been tried. In several cases, the plaintiffs have received large verdicts, but in an equal number of trials Merck has obtained a defense verdict.

Click to download the article featured in Law Week Colorado:
"At Vioxx's End – Most Who Qualify Will Take Deal, Burg Predicts"

Other Press Releases

If you believe you have suffered a claim because you used Vioxx, please call or email us today for a free consultation. At Burg Simpson Eldredge Hersh & Jardine, P.C., our Colorado attorneys represent people who have suffered injuries because of dangerous drugs like Vioxx.

Return to the Dangerous Drugs Section

Colorado Wyoming Ohio Arizona

Vioxx Litigation Attorneys

in Colorado and Nationwide

$5,350,000

$1,300,000

$690,000,000

$5,800,000